Proactive protection This trend captures a universal human truth – when the world feels uncertain, we cling to what we can ...

Gilead Sciences’ Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets) has been approved by the ...

The US Food and Drug Administration (FDA) has approved Apellis Pharmaceuticals’ Sobi-partnered Empaveli (pegcetacoplan) to ...

AstraZeneca (AZ) has announced that Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) has been recommended by ...

The most widely used measure of health-related self-efficacy is the Patient Activation Measure (PAM). It is a ...

In exchange, Hengrui will receive $500m in upfront fees and will be eligible for approximately $12bn in development, ...

The US Food and Drug Administration (FDA) has approved PTC Therapeutics’ Sephience (sepiapterin) to treat the rare metabolic ...

Typically, when organisations speak of supply chain transparency, they focus on the last mile: the product journey from ...

Eli Lilly’s Alzheimer’s disease (AD) drug Kisunla ( donanemab) has demonstrated a growing benefit over three years in ...

AbbVie has shared promising top-line results from a late-stage study of its JAK inhibitor Rinvoq (upadacitinib) in severe ...

The Cannes Lions International Festival of Creativity is known for its topical breadth – and the smart pharma marketers who ...

Over the decades, I’ve probably worked with as many low performance brand teams as high performance ones. Typically, their ...